semaglutide gastric intestinal obstruction lawsuit in michigan GLP-1 Lawsuits: What to Know as a Prescriber michigan semaglutide gastric intestinal obstruction
Description
Kormann, M
A switch from semaglutide to tirzepatide does not guarantee fewer GI symptoms
doi: 10.1007/s11695-015-1902-5
Patients may: ::trust the wrong dose ::delay proper medical care ::experience adverse events with no safety net FDA is protecting truth in medicine, not just labels
Fortunately, since Oral Wegovy is an FDA-approved branded medication, it is often covered by insurance plans, although prior authorization may be necessary
